retatrutide glucagon receptor agonist The data just dropped — and is rewriting what's possible in obesity medicine. 🧬 TRIUMPH-1 just released Phase 3 results, and the numbers are unlike anything we've seen from a medication Retatrutide for weight loss: Study

Human islets from Edmonton were provided by the Clinical Islet Transplant Program and by the Alberta Diabetes Institute Islet Core at the University of Alberta with the assistance of the Human Organ Procurement and Exchange (HOPE) program, Trillium Gift of Life Network (TGLN) and other Canadian organ procurement organizations

Lets use Ozempic as an example

For example, we dont yet understand how somebodys microbiome may influence how well they respond to GLP-1 drugs or the degree to which they suffer from side effects. Added to this, research hasnt yet determined how a users gut microbiome changes when they take these drugs and what impact that could have

[1] [2] The medication is administered as a once-weekly subcutaneous injection and works systemically to regulate appetite and glucose metabolism